Stocks making the biggest moves midday: Bed Bath & Beyond, Nio, Joby Aviation, Teva & more

Stocks making the biggest moves midday: Bed Bath & Beyond, Nio, Joby Aviation, Teva & more


A person enters a Bed Bath & Beyond store in the Tribeca neighborhood in New York City.

Michael M. Santiago | Getty Images

Check out the companies making headlines in midday trading Friday.

Bed Bath & Beyond – Shares of the home goods retailer popped more than 4% in midday trading after the company announced that three people from activist investor Ryan Cohen’s firm, RC Ventures, will immediately join Bed Bath & Beyond’s board.

Nio – The U.S.-traded shares of the Chinese electric vehicle maker dropped 10% after Nio reported its fourth-quarter results. Nio’s fourth-quarter revenue beat expectations, but its forward guidance came in below StreetAccount estimates.

Joby Aviation – The electric aviation company’s stock jumped 12% on the back of its latest quarterly results. Joby reported earnings of 1 per share after losing 31 cents per share in the year-earlier period. Morgan Stanley also reiterated the stock as overweight, noting that Joby continues to gain steam and take “meaningful steps forward in the certification and manufacturing process.”

Teva – Shares of the drugmaker gained 4.7% after Bernstein upgraded the stock to outperform from market perform, as Teva launches new products and looks to potentially settle ongoing opioid litigation.

Honest Company – Shares of the consumer goods company plummeted 25% on the back of mixed quarterly numbers. The Honest Company said it lost 10 cents per share on $80.4 million in revenue. Analysts expected a loss of 6 cents per share on $84.6 million in revenue, according to Refinitiv.

Fortinet – Fortinet fell 2.7% after Bank of America downgraded to neutral from buy. The bank said strong earnings growth is already baked into Fortinet’s stock.

Alibaba, JD.com — Chinese technology stocks listed in the U.S. fell again on Friday, as they continue to face increased scrutiny in China and potential U.S. delistings. Alibaba fell 3.1%, JD.com lost 3%, and Pinduoduo slid 4%. Didi Global plummeted nearly 14%.

— CNBC’s Maggie Fitzgerald, Jesse Pound and Sarah Min contributed reporting



Source

FDA chief warns U.S. is losing ground to China in early drug development, calls for faster trial approvals
Business

FDA chief warns U.S. is losing ground to China in early drug development, calls for faster trial approvals

Food and Drug Administration Commissioner Marty Makary warned that the U.S. is falling behind China in early-stage drug development and called for reforms that could streamline the process for starting trials on new treatments.  In an interview with CNBC on Wednesday, Makary specifically pointed to three bottlenecks that he said cause the U.S. to fall […]

Read More
Seattle Seahawks begin sale process after Super Bowl win
Business

Seattle Seahawks begin sale process after Super Bowl win

Dareke Young #83 of the Seattle Seahawks celebrates with teammates during the third quarter of the NFC Championship game against the Los Angeles Rams at Lumen Field on Jan. 25, 2026 in Seattle, Washington. Jane Gershovich | Getty Images The Seattle Seahawks are officially up for sale. The NFL team, which defeated the New England […]

Read More
FDA chief Marty Makary says ‘everything should be over the counter’ unless drug is unsafe or addictive
Business

FDA chief Marty Makary says ‘everything should be over the counter’ unless drug is unsafe or addictive

Food and Drug Administration Commissioner Marty Makary told CNBC that he believes “everything should be over the counter” unless a drug is unsafe, addictive or requires monitoring – doubling down on a push that some in the pharmaceutical industry have questioned.  In an interview Wednesday in Washington, D.C., Makary said the FDA aims to make […]

Read More